 HAYWARD, Calif.--BUSINESS WIRE--Pulse Biosciences, Inc. Nasdaq: PLSE, a novel bioelectric medicine company introducing the CellFX System powered by Nano-Pulse StimulationTM NPSTM technology, today announced the podium presentation of four clinical studies of NPS technology at the American Society for Laser Medicine and Surgery ASLMS Virtual Annual Meeting taking place on May 15-16, 2021. Recent results will be presented on the use of CellFXs non-thermal, cellular-specific NPS technology 